Currently there is only one treatment option available for mesothelioma that is approved by the FDA. As with any other rare form of cancer, a mesothelioma patient may want to consider other options. Clinical trials provide mesothelioma patients with the opportunity for a newer, innovative treatment plan for the disease.
The Philadelphia mesothelioma lawyers at the Brookman, Rosenberg, Brown & Sandler are happy to provide information for mesothelioma patients considering a clinical trial. The Mesothelioma Applied Research Foundation (MARF) has compiled an informational brochure for those diagnosed with the disease. MARF is a non-profit group that focuses its efforts on eliminating the disease and advocating for its victims.
To view MARF’s online resource material, click here.
A mesothelioma patient must meet certain specific guidelines before entering into a clinical trial. Moreover, it is always a good idea to ensure that all benefits of the trial, as well as the risks, are reviewed before consenting to any treatment option.
For more information on the rights of mesothelioma victims, contact our Philadelphia and New Jersey asbestos lawyers at Brookman, Rosenberg, Brown & Sandler by calling 215-569-4000 to schedule an appointment or contact us online.